Request for Covid-19 Impact Assessment of this Report
23-Valent Pneumococcal Polysaccharide Vaccine is a kind of vaccine used to prevent infection caused by pneumococcal bacteria. 23-Valent Pneumococcal Polysaccharide Vaccine contains 23 of the most common types of pneumococcal bacteria.
23-Valent Pneumococcal Polysaccharide Vaccine is for use only in adults and children who are at least 2 years old. For children younger than 2 years old, another vaccine called Prevnar (pneumococcal conjugate vaccine [PCV] 7-valent) is used, usually given between the ages of 2 months and 15 months.
In this report, the data of China comes from NICPBP (National Institutes for Food and Drug Control).
ICRWorld’s 23-Valent Pneumococcal Polysaccharide Vaccine market research report provides the newest industry data and industry future trends, allowing you to identify the products and end users driving revenue growth and profitability.
The industry report lists the leading competitors and provides the insights strategic industry analysis of the key factors influencing the market.
The report includes the forecasts, analysis and discuion of important industry trends, market size, market share estimates and profiles of the leading industry players.
Global 23-Valent Pneumococcal Polysaccharide Vaccine Market: Product Segment Analysis
Single Dose Vial
Pre-filled Syringe
Global 23-Valent Pneumococcal Polysaccharide Vaccine Market: Application Segment Analysis
For Children (2-10)
For Person (10-64)
For The old (?65)
Global 23-Valent Pneumococcal Polysaccharide Vaccine Market: Regional Segment Analysis
USA
Europe
Japan
China
India
South East Asia
The players mentioned in our report
MSD
Sanofipasteur
CDIBP
Chapter 1 About the 23-Valent Pneumococcal Polysaccharide Vaccine Industry
1.1 Industry Definition
1.1.1 Types of 23-Valent Pneumococcal Polysaccharide Vaccine industry
1.2.1.1 Single Dose Vial
1.2.1.2 Pre-filled Syringe
1.2 Main Market Activities
1.3 Similar Industries
1.4 Industry at a Glance
Chapter 2 World Market Competition Landscape
2.1 23-Valent Pneumococcal Polysaccharide Vaccine Markets by regions
2.1.1 USA
Market Revenue by types, Through 2021
Market overview
Major players Revenue in 2015
2.1.2 Europe
Market Revenue by types, Through 2021
Market overview
Major players Revenue in 2015
2.1.3 China
Market Revenue by types, Through 2021
Market overview
Major players Revenue in 2015
2.1.4 India
Market Revenue by types, Through 2021
Market overview
Major players Revenue in 2015
2.1.5 Japan
Market Revenue by types, Through 2021
Market overview
Major players Revenue in 2015
2.1.6 South East Asia
Market Revenue by types, Through 2021
Market overview
Major players Revenue in 2015
2.2 World 23-Valent Pneumococcal Polysaccharide Vaccine Market by types
Single Dose Vial
Pre-filled Syringe
2.3 World 23-Valent Pneumococcal Polysaccharide Vaccine Market by Applications
For Children (2-10)
For Person (10-64)
For The old (?65)
Chapter 3 World 23-Valent Pneumococcal Polysaccharide Vaccine Market share
3.1 Major players Market share by production
3.2 Major players Market share by Revenue
3.3 Major Regions Market share by Production in 2015, Through 2021
3.4 Major Regions Market share By Revenue in 2015, Through 2021
Chapter 4 Supply Chain
4.1 Industry Supply chain Analysis
4.2 Raw material Market analysis
4.2.1 Raw material Prices analysis 2012-2016
4.2.2 Raw material Supply Market analysis
4.2 Manufacturing Equipment Suppliers Analysis
4.3 Production Proce Analysis
4.4 Production Cost Structure Benchmarks
4.5 End users Market Analysis
Chapter 5 Company Profiles
5.1 MSD
5.1.1 Company Details (Foundation Year, Employee Strength and etc)
5.1.2 Product Information (Picture, Specifications and Applications)
5.1.3 Revenue, Price and Operating Profits
5.2 Sanofipasteur
5.2.1 Company Details (Foundation Year, Employee Strength and etc)
5.2.2 Product Information (Picture, Specifications and Applications)
5.2.3 Revenue, Price and Operating Profits
5.10 CDIBP
5.10.1 Company Details (Foundation Year, Employee Strength and etc)
5.10.2 Product Information (Picture, Specifications and Applications)
5.10.3 Revenue, Price and Operating Profits
Chapter 6 Globalisation & Trade
6.1 Busine Locations
6.2 Supply channels
6.3 Marketing strategy
6.4 Barriers to Entry
Chapter 7 Distributors and Customers
7.1 Major Distributors and contact information by regions
7.2 Major Customers and contact information by regions
Chapter 8 Import, Export, Consumption and Consumption Value by Major Countries
8.1 USA
8.2 Germany
8.3 China
8.4 Japan
8.5 India
8.6 South East Asia
Chapter 9 World 23-Valent Pneumococcal Polysaccharide Vaccine Market Forecast through 2021
9.1 World 23-Valent Pneumococcal Polysaccharide Vaccine Demand by Regions Forecast through 2021
9.2 World 23-Valent Pneumococcal Polysaccharide Vaccine Price(by Regions, Types, Applications)Analysis Forecast through 2021
9.3 World 23-Valent Pneumococcal Polysaccharide Vaccine Revenue(by Regions, Types, Applications) Forecast through 2021
Chapter 10 Key succe factors and Market Overview
Tables and figures
Table Main Market Activities by Regions
Table Market Revenue by types, Through 2021
Table Major players Revenue in 2015
Table Market Revenue by types, Through 2021
Table Major players Revenue in 2015
Table Market Revenue by types, Through 2021
Table Major players Revenue in 2015
Table Market Revenue by types, Through 2021
Table Major players Revenue in 2015
Table Market Revenue by types, Through 2021
Table Major players Revenue in 2015
Table Major players Market share by production 2015
Table Major players Market share by Revenue 2015
Table Major Regions Market share by Production in 2015-2016
Table Major Regions Market share by Production in 2017-2021
Table Major Regions Market share by Revenue in 2015-2016
Table Major Regions Market share by Revenue in 2017-2021
Table Industry Supply chain Analysis
Table Raw material Prices analysis 2012-2016
Table Raw material Suppliers Market analysis
Table Manufacturing Equipment Suppliers Analysis
Figure Production Proce Analysis
Figure Production Cost Structure
Table major End Users by regions
Table MSD Information List
Figure 23-Valent Pneumococcal Polysaccharide Vaccine23-Valent Pneumococcal Polysaccharide Vaccine Picture, Specifications and Applications of MSD
Table 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of MSD 2015
Figure 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume (K Doses) and World Market Share of MSD 2015
Table Sanofipasteur Information List
Figure 23-Valent Pneumococcal Polysaccharide Vaccine Picture, Specifications and Applications of Sanofipasteur
Table 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of Sanofipasteur 2015
Figure 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume (K Doses) and World Market Share of Sanofipasteur 2015
Table CDIBP Information List
Figure 23-Valent Pneumococcal Polysaccharide Vaccine Picture, Specifications and Applications of CDIBP
Table 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of CDIBP 2015
Figure 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume (K Doses) and World Market Share of CDIBP 2015
Table Busine Locations
Figure Supply channels
Figure Marketing strategy
Table Barriers Analysis to Entry
Table Major Distributors and contact information by regions
Table Major Customers and contact information by regions
Table USA Supply, Import, Export, Consumption (K Doses) and Consumption Value(M USD)
Table Germany Supply, Import, Export, Consumption(K Doses) and Consumption Value(M USD)
Table China Supply, Import, Export, Consumption(K Doses) and Consumption Value(M USD)
Table Japan Supply, Import, Export, Consumption(K Doses) and Consumption Value(M USD)
Table India Supply, Import, Export, Consumption(K Doses) and Consumption Value(M USD)
Table South East Asia Supply, Import, Export, Consumption(23-Valent Pneumococcal Polysaccharide Vaccines) and Consumption Value(M USD)
Table World Demand (K Doses) by Regions Forecast Analysis of 23-Valent Pneumococcal Polysaccharide Vaccine (2016-2021)
Table World Price by Regions Forecast Analysis of 23-Valent Pneumococcal Polysaccharide Vaccine (2016-2021)
Table World Price by Types Forecast Analysis of 23-Valent Pneumococcal Polysaccharide Vaccine (2016-2021)
Table World Price by Applications Forecast Analysis of 23-Valent Pneumococcal Polysaccharide Vaccine (2016-2021)
Table World Revenue by Regions Forecast Analysis of 23-Valent Pneumococcal Polysaccharide Vaccine (2016-2021)
Table World Revenue (M USD) by Types Forecast Analysis of 23-Valent Pneumococcal Polysaccharide Vaccine (2016-2021)
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...